We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ProCure Proton Centers Select RayStation® for Proton Planning

Product News   Dec 26, 2013

 
ProCure Proton Centers Select RayStation® for Proton Planning
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

VAXIMM To Announce First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy in Combination with Avelumab

Product News

VAXIMM has announced that the safety run-in results from the trial are being presented as an oral presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Meeting.

READ MORE

New Transcreener CD73 Assay for Discovery of Therapeutics to Enhance Tumor Immunity

Product News

Researchers at BellBrook Labs have developed a high throughput screening (HTS) assay to discover small molecule modulators for the immunosuppressive ectonucleotidase, CD73.

READ MORE

Promising Phase 2a Data on Prostate Cancer Immunotherapy

Product News

Vaccitech Limited and the University of Oxford have announced initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE